https://doi.org/10.1038/sj.bjc.6601579
J
J. Blake Bartlett
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
3.8K
Citations
22
h-index
27
i10-index
J. Blake Bartlett is an academic researcher. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 22, co-authored 59 publications.
Papers by this author
worksPhase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
2004 · British Journal of Cancer · 139 citations
The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival
2006 · British Journal of Cancer · 52 citations
https://doi.org/10.1038/sj.bjc.6603104
Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)
2009 · British Journal of Cancer · 40 citations
https://doi.org/10.1038/sj.bjc.6605206
P-329 Diagnostic Challenges Across the Multiple Myeloma Pathway: Perspectives of Primary Care Physicians and Orthopedic Specialists
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)02231-6
Preclinical Analysis of Ciltacabtagene Autoleucel Combination Strategies with T Cell Bispecifics and Daratumumab to Support Optimization of Clinical Benefit in Myeloma Patients
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03515-3
Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)04013-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat